Tumour necrosis factor (TNF ) as a novel therapeutic target in symptomatic corticosteroid dependent asthma

Abstract

These findings may be of clinical significance in identifying TNFalpha as a new therapeutic target in subjects with severe asthma. The effects of anti-TNF treatment now require confirmation in placebo controlled studies.